Forward Pharma A/S American Depositary Shares
FWP was delisted on the 27th of December, 2022.
10 hedge funds and large institutions have $10.2M invested in Forward Pharma A/S American Depositary Shares in 2019 Q3 according to their latest regulatory filings, with 0 funds opening new positions, 6 increasing their positions, 2 reducing their positions, and 2 closing their positions.
200% more repeat investments, than reductions
Existing positions increased: 6 | Existing positions reduced: 2
0% more capital invested
Capital invested by funds: $10.1M → $10.2M (+$9.04K)
17% less funds holding
Funds holding: 12 → 10 (-2)
100% less first-time investments, than exits
New positions opened: 0 | Existing positions closed: 2
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
NM
Newtyn Management
New York
|
+$1.98M |
| 2 |
Morgan Stanley
New York
|
+$5.71K |
| 3 |
PCG
Private Capital Group
West Hartford,
Connecticut
|
+$838 |
| 4 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$725 |
| 5 |
UBS Group
Zurich,
Switzerland
|
+$559 |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BI
BVF Inc
San Francisco,
California
|
-$1.9M |
| 2 |
Citadel Advisors
Miami,
Florida
|
-$5.96K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
BI
1
BVF Inc
San Francisco,
California
| $6.61M | -$1.9M | -285,714 | -24% |
|
|
NM
2
Newtyn Management
New York
| $3.27M | +$1.98M | +297,500 | +185% |
|
|
3
Morgan Stanley
New York
| $231K | +$5.71K | +858 | +3% |
|
|
4
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
| $21K | +$725 | +109 | +4% |
|
|
5
Citadel Advisors
Miami,
Florida
| $11K | -$5.96K | -895 | -37% |
|
|
AG
6
Advisor Group
Phoenix,
Arizona
| $1K | +$439 | +66 | +94% |
|
|
7
UBS Group
Zurich,
Switzerland
| $1K | +$559 | +84 | +494% |
|
|
PCG
8
Private Capital Group
West Hartford,
Connecticut
| $1K | +$838 | +126 | +663% |
|
|
RCAG
9
Rehmann Capital Advisory Group
Lansing,
Michigan
| $442 | – | – | – |
|
FWP Hedge Fund Activity: Q3 2019 in Review
10 of the 4,560 institutional investors tracked by Wall St. Rank reported a position in Forward Pharma A/S American Depositary Shares (FWP) for Q3 2019, worth a combined $10.2M — up 0.09% from $10.1M a quarter earlier.
Sellers outnumbered buyers: 2 funds closed out of FWP and 0 opened new positions — a net loss of 2 holders — while 2 trimmed existing stakes and 6 added.
The largest buyer was Newtyn Management, adding an estimated $1.98M. The largest seller was BVF Inc, cutting an estimated $1.9M.
- 10 institutional investors held Forward Pharma A/S American Depositary Shares (FWP) as of Q3 2019, down from 12 in Q2 2019.
- Funds reported $10.2M of Forward Pharma A/S American Depositary Shares stock for Q3 2019, up 0.09% quarter-over-quarter.
- 0 funds opened new Forward Pharma A/S American Depositary Shares positions in Q3 2019 and 2 closed out, a net change of -2 holders.
- The largest Forward Pharma A/S American Depositary Shares buyer in Q3 2019 was Newtyn Management, an estimated $1.98M added.
- The largest Forward Pharma A/S American Depositary Shares seller in Q3 2019 was BVF Inc, an estimated $1.9M sold.
Based on aggregated 13F filings for Q3 2019.